Search Result "sodium-glucose cotransporter-2 (SGLT2) inhibitors"
Sodium-glucose Cotransporter 2 Inhibitors and Pathological MyocardialHypertrophy
Journal: Current Drug Targets
Volume: 24 Issue: 13 Year: 2023 Page: 1009-1022
Author(s):
Discovery of 6-Deoxydapagliflozin as a Highly Potent Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
Journal: Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2014 Page: 304-317
Author(s): Lingyu Zhang,Yuli Wang,Huaqiang Xu,Yongheng Shi,Bingni Liu,Qunchao Wei,Weiren Xu,Lida Tang,Jianwu Wang,Guilong Zhao
Sodium-glucose Cotransporter Type 2 Inhibitors: A New Insight into the MolecularMechanisms of Diabetic Nephropathy
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 26 Year: 2022 Page: 2131-2139
Author(s):
Recent Advances in the Development of Type 2 Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 4 Year: 2022 Page: 586-599
Author(s): Ana Karen Estrada,Timoteo Delgado-Maldonado,Edgar E. Lara-RamÃrez,Ana Verónica MartÃnez-Vázquez,Eyra Ortiz-Lopez,Alma D. Paz-González,Debasish Bandyopadhyay,Gildardo Rivera
The Emerging Role of Sodium-glucose Cotransporter 2 Inhibitors in HeartFailure
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 7 Year: 2023 Page: 481-493
Author(s): Giulio G. Stefanini
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1522-1532
Author(s): Niki Katsiki,Dimitri P. Mikhailidis,Michael J. Theodorakis
Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-Of-The-Art Review
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 20 Issue: 0 Year: 2022 Page: 1-13
Author(s): Mauro Gitto,Dimitrios A. Vrachatis,Gianluigi Condorelli,Konstantinos Papathanasiou,Bernhard Reimers,Spyridon Deftereos,Giulio G Stefanini
Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition with Canagliflozin in Type 2 Diabetes Mellitus
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2013 Page: 203-206
Author(s): Sarmad Said,German T. Hernandez
Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for New Anti-Diabetic Agent
Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 4 Year: 2010 Page: 411-418
Author(s): Sumihiro Nomura
Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitorsin the Diabetic Milieu
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 2 Year: 2024 Page: 138-151
Author(s):